Insights from ESMO Breast 2024 Annual Meeting
Playback speed
10 seconds
ESMO Breast 2024 Insights: "CAPItello-291 Trial PFS2 & TFSC Updates - Capivasertib & Fulvestrant for Patients With Aromatase Inhibitor-Resistant HR+/HER2- Advanced BC"
By
Insights from ESMO Breast 2024 Annual Meeting
FEATURING
Hope Rugo
By
Insights from ESMO Breast 2024 Annual Meeting
FEATURING
Hope Rugo
336 views
May 22, 2024
Comments 0
Login to view comments.
Click here to Login
Videos